27 studies found for:    omalizumab, urticaria
Show Display Options
Download search resultsDownload the search results for:
omalizumab, urticaria (27 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment
Condition: CHRONIC SPONTANEOUS URTICARIA
Intervention: Drug: OMALIZUMAB
2 Completed
Has Results
Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria
Condition: Chronic Urticaria
Interventions: Drug: Omalizumab 75-375 mg;   Drug: Placebo to omalizumab;   Drug: Loratadine;   Drug: Clemastine
3 Completed Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients
Conditions: Chronic Urticaria;   Chronic Idiopathic Urticaria;   Chronic Spontaneous Urticaria
Interventions: Drug: Omalizumab (Xolair);   Drug: Placebo
4 Unknown  Efficacy and Safety of Omalizumab in Patients With Severe Acute Urticaria
Condition: Urticaria
Intervention: Drug: omalizumab
5 Completed
Has Results
A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)
Condition: Chronic Idiopathic Urticaria
Interventions: Drug: omalizumab;   Drug: placebo;   Drug: H1 antihistamines;   Drug: Diphenhydramine
6 Recruiting Sustained Effect of Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab Discontinuation
Condition: Urticaria
Interventions: Dietary Supplement: Vitamin D (4,000 IU/day);   Dietary Supplement: Vitamin D (400 IU/day);   Drug: Omalizumab
7 Completed
Has Results
Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment
Condition: Chronic Idiopathic Urticaria
Interventions: Drug: IGE025;   Drug: placebo
8 Active, not recruiting Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria
Condition: Chronic Urticaria
Intervention: Drug: Omalizumab
9 Completed Omalizumab in Severe and Refractory Solar Urticaria
Condition: Solar Urticaria
Intervention: Drug: Omalizumab
10 Recruiting OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients
Condition: Chonic Spontaneous Urticaria
Intervention: Drug: omalizumab
11 Not yet recruiting Three-month, Single-center Study to Identify Biomarkers/Response to Xolair Therapy in Chronic Idiopathic Urticaria
Condition: Chronic Idiopathic Urticaria
Intervention: Biological: Xolair
12 Completed
Has Results
Urticaria Facticia Treatment With Omalizumab (UFO)
Condition: Symptomatic Dermographism
Interventions: Drug: Omalizumab;   Drug: Placebo
13 Enrolling by invitation Efficacy and Safety Study of Omalizumab (Xolair®) to Treat Chronic Urticaria
Condition: Chronic Urticaria
Interventions: Biological: Omalizumab;   Biological: Placebo
14 Completed
Has Results
A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists
Condition: Chronic Idiopathic Urticaria
Interventions: Drug: Omalizumab;   Drug: Placebo;   Drug: H1 antihistamine, H2 antihistamine, leukotriene receptor antagonist;   Drug: Diphenhydramine
15 Completed
Has Results
Cold Urticaria Treatment With Xolair
Condition: Cold Contact Urticaria
Interventions: Drug: Omalizumab;   Drug: Placebo
16 Active, not recruiting Efficacy Study of Omalizumab in Cholinergic Urticaria
Condition: Cholinergic Urticaria
Interventions: Biological: Active;   Biological: Placebo;   Biological: Open labeled
17 Completed
Has Results
A Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1)
Condition: Chronic Idiopathic Urticaria
Interventions: Drug: Placebo;   Drug: Omalizumab
18 Completed
Has Results
A Study of the Efficacy and Safety of Omalizumab (Xolair) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine (H1) Treatment
Condition: Chronic Idiopathic Urticaria
Interventions: Drug: Omalizumab;   Drug: Placebo
19 Completed Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy
Conditions: Chronic Spontaneous Urticaria;   Angioedema
Interventions: Biological: Omalizumab;   Drug: Placebo
20 Unknown  Efficacy and Safety of Omalizumab in Chronic Idiopathic Urticaria
Condition: Chronic Idiopathic Urticaria
Intervention: Drug: Omalizimab

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Indicates status has not been verified in more than two years